Advanced Oncotherapy (AVO) – Director Dealing
Advanced Oncotherapy (AIM: AVO), the developer of next-generation proton therapy systems for cancer treatment, announces that it was informed on Friday 8 July 2016 that Fairford Capital Ltd, of which Michael Bradfield, a Non-Executive Director of the Company, is the sole beneficial owner, on Friday 8 July 2016 purchased 10,000 ordinary shares of 25 pence […]
Advanced Oncotherapy (AVO) – Director Dealing
Advanced Oncotherapy (AIM: AVO), the developer of next-generation proton therapy systems for cancer treatment, announces that it was informed yesterday that Fairford Capital Ltd, of which Michael Bradfield, a Non-Executive Director of the Company, is the sole beneficial owner, yesterday purchased 10,000 ordinary shares of 25 pence each in the Company at 112.0 pence per […]
Advanced Oncotherapy (AVO) – Director Dealing
Advanced Oncotherapy (AIM: AVO), the developer of next-generation proton therapy systems for cancer treatment, announces that it was informed yesterday that Fairford Capital Ltd, of which Michael Bradfield, a Non-Executive Director of the Company, is the sole beneficial owner, yesterday purchased 50,000 ordinary shares of 25 pence each in the Company at 102.5 pence per […]
Advanced Oncotherapy (AVO) – Result of AGM and share consolidation
Advanced Oncotherapy (AIM: AVO), the developer of next-generation proton therapy systems for cancer treatment, announces that at the Annual General Meeting held earlier today, all resolutions were duly passed. Share Consolidation Following the passing of the share consolidation resolution, every 25 existing ordinary shares of 1 penny each (“Existing Ordinary Shares”) that are in issue […]
Advanced Oncotherapy (AVO) – AGM Presentation
Advanced Oncotherapy plc (AVO), the developer of next-generation proton therapy systems for cancer treatment, will hold its Annual General Meeting at 12.00 noon at the Royal Institute of British Architects, 66 Portland Place, London W1B 1AD on Thursday, 30 June 2016. The Company will provide shareholders with a short presentation on its development so far and […]
Advanced Oncotherapy (AVO) – Exercise of options and issue of shares
Advanced Oncotherapy (AVO), the developer of next-generation proton therapy systems for cancer treatment, announces that it has agreed to issue 1,166,666 new ordinary shares of 1p in the Company pursuant to the exercise of options at 2.7 pence per New Share Application has been made for the 1,166,666 New Shares to be admitted to trading […]
Advanced Oncotherapy (AVO) – Final Results for the year ended 31 December 2015
Advanced Oncotherapy (AVO), the developer of next generation proton therapy systems for cancer treatment, announces audited results for the year ended 31 December 2015, a year of good progress in the development of the Company’s LIGHT system. Highlights: Oversubscribed placing to raise £20 million (net) to develop and install first LIGHT system Sale of two […]
Advanced Oncotherapy (AVO) secures of £24m financing for Harley Street
Advanced Oncotherapy (AVO), the developer of next-generation proton therapy systems for cancer treatment, announces that it has signed an agreement with a fund advised by Metric Capital Partners LLP, a pan-European private capital fund manager, whereby Metric Capital will invest £24 million in a financing facility to support the Company’s provision of vendor financing for the […]
I’m Banging on About this Cancer-Zapper, Again – But It’s Still on Course for Share Success – Malcolm Stacey at ShareProphets
Parts 1 and 2 by Malcolm Stacey 1) Hello Share Crafters. In the past I’ve probably written too many pieces on a medical share which I like. During that period, I’ve seen the shares rise from 2p to 17p. Sadly, the share price has reversed back to 6.5p. And the worst of it is I […]
Advanced Oncotherapy (AVO) – Holdings in Company
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii Advanced Oncotherapy plc 2 Reason for the notification (please tick the appropriate box or boxes): An acquisition or disposal of voting rights An acquisition or disposal of qualifying […]